Skip Navigation
American College of Physicians Logo
  • Subscribe
  • Submit a Manuscript
  • Sign In
    Sign in below to access your subscription for full content
    INDIVIDUAL SIGN IN
    Sign In|Set Up Account
    You will be directed to acponline.org to register and create your Annals account
    INSTITUTIONAL SIGN IN
    Open Athens|Shibboleth|Log In
    Annals of Internal Medicine
    SUBSCRIBE
    Subscribe to Annals of Internal Medicine.
    You will be directed to acponline.org to complete your purchase.
Annals of Internal Medicine Logo Menu
  • Latest
  • Issues
  • Channels
  • CME/MOC
  • In the Clinic
  • Journal Club
  • Web Exclusives
  • Author Info
Advanced Search
  • ‹ PREV ARTICLE
  • This Issue
  • NEXT ARTICLE ›
Summaries for Patients |16 October 2001

Selecting Patients with Colorectal Cancer To Test for Genetic Abnormalities

  • ‹ PREV ARTICLE
  • This Issue
  • NEXT ARTICLE ›
Jump To
  • Full Article
  • FULL ARTICLE
  • FULL ARTICLE
    • What is the problem and what is known about it so far?
    • Why did the researchers do this particular study?
    • Who was studied?
    • How was the study done?
    • What did the researchers find?
    • What were the limitations of the study?
    • What are the implications of the study?
  • Figures
  • Tables
  • Supplements
  • Audio/Video
  • Summary for Patients
  • Clinical Slide Sets
  • CME / MOC
  • Comments
  • Twitter Link
  • Facebook Link
  • Email Link
More
  • LinkedIn Link

What is the problem and what is known about it so far?

Colorectal cancer affects the colon (large intestine) or rectum. An inherited cancer syndrome called hereditary nonpolyposis colorectal cancer (HNPCC) is the cause of colorectal cancer in some patients. People with HNPCC have a higher than usual risk for colorectal and several other types of cancer. In HNPCC, colorectal tumors have a DNA abnormality (DNA is the substance that makes up genes) called microsatellite instability. In addition, people with HNPCC frequently have abnormalities (mutations) in two genes known as MLH1 and MSH2. Patients with an MLH1 or MSH2 mutation are more likely to have colorectal tumors with microsatellite instability than are patients without these mutations. Identifying patients with an MLH1 or MSH2 mutation may be important so that they and their family members can be monitored closely for the development of colorectal tumors. The Bethesda guidelines identify conditions that suggest that a patient mi t have HNPCC (for example, colorectal cancer in two successive generations or cancer at a young age). However, many people who meet a Bethesda criterion do not have HNPCC. It would be useful to have a way to identify people with colorectal cancer who should undergo genetic testing for mutations in MLH1 and MSH2.

Why did the researchers do this particular study?

To find out whether combining the Bethesda criteria with tests for microsatellite instability can help identify people with HNPCC mutations in the MLH1 and MSH2 genes.

Who was studied?

125 patients with colorectal cancer at a university hospital in Germany.

How was the study done?

The researchers classified the study patients as meeting or not meeting Bethesda criteria and then tested all patients for microsatellite instability. Patients with microsatellite instability were then tested for MLH1 and MSH2 mutations.

What did the researchers find?

Of the 58 patients who met Bethesda criteria, 17 had microsatellite instability compared with only 5 of the 67 patients who did not meet any Bethesda criterion. Eleven of the 17 patients with microsatellite instability who met Bethesda criteria had at least one of the HNPCC mutations compared with no mutations in the patients with microsatellite instability who did not meet any Bethesda criterion.

What were the limitations of the study?

The number of patients with an HNPCC mutation was small; therefore, the accuracy of the Bethesda criteria combined with microsatellite instability is uncertain. This study does not tell us whether genetic testing actually helped patients or their family members.

What are the implications of the study?

Patients with colorectal cancer who meet Bethesda criteria and have microsatellite instability are more likely to have HNPCC mutations than patients who do not. Patients who do not meet Bethesda criteria and have microsatellite instability are unlikely to have these mutations. Patients who meet at least one Bethesda criterion and have a tumor that shows microsatellite instability should undergo testing for MLH1 and MSH2 mutations.

Clinical Slide Sets

Terms of Use

The In the Clinic® slide sets are owned and copyrighted by the American College of Physicians (ACP). All text, graphics, trademarks, and other intellectual property incorporated into the slide sets remain the sole and exclusive property of the ACP. The slide sets may be used only by the person who downloads or purchases them and only for the purpose of presenting them during not-for-profit educational activities. Users may incorporate the entire slide set or selected individual slides into their own teaching presentations but may not alter the content of the slides in any way or remove the ACP copyright notice. Users may make print copies for use as hand-outs for the audience the user is personally addressing but may not otherwise reproduce or distribute the slides by any means or media, including but not limited to sending them as e-mail attachments, posting them on Internet or Intranet sites, publishing them in meeting proceedings, or making them available for sale or distribution in any unauthorized form, without the express written permission of the ACP. Unauthorized use of the In the Clinic slide sets will constitute copyright infringement.

This feature is available only to Registered Users

Subscribe/Learn More
Submit a Comment

0 Comments

PDF
Not Available
Citations
Citation

Selecting Patients with Colorectal Cancer To Test for Genetic Abnormalities. Ann Intern Med. 2001;135:S47. doi: https://doi.org/10.7326/0003-4819-135-8_Part_1-200110160-00003

Download citation file:

  • Ris (Zotero)
  • EndNote
  • BibTex
  • Medlars
  • ProCite
  • RefWorks
  • Reference Manager

© 2019

×
Permissions

Published: Ann Intern Med. 2001;135(8_Part_1):S47.

DOI: 10.7326/0003-4819-135-8_Part_1-200110160-00003

0 Citations

See Also

Bethesda Guidelines: Relation to Microsatellite Instability and MLH1 Promoter Methylation in Patients with Colorectal Cancer
View MoreView Less

Related Articles

The Genetics of Colorectal Cancer
Annals of Internal Medicine; 137 (7): I-48
The Genetics of Colorectal Cancer
Annals of Internal Medicine; 137 (7): 603-612
Colorectal Cancer: Evidence for Distinct Genetic Categories Based on Proximal or Distal Tumor Location
Annals of Internal Medicine; 113 (10): 779-788
After surgery for stage II or III colorectal cancer, more vs less frequent follow-up did not differ for 5-year mortality
Annals of Internal Medicine; 169 (8): JC38
View MoreView Less

Journal Club

After surgery for stage II or III colorectal cancer, more vs less frequent follow-up did not differ for 5-year mortality
Annals of Internal Medicine; 169 (8): JC38
Review: Aspirin reduces colorectal cancer incidence and mortality in patients at average risk
Annals of Internal Medicine; 165 (4): JC16
Review: Providing genetic-based risk estimates for disease does not affect risk-reducing behaviors in adults
Annals of Internal Medicine; 164 (12): JC65
Invitation for flexible sigmoidoscopy screening reduced colorectal cancer and colorectal cancer mortality
Annals of Internal Medicine; 161 (12): JC2
View MoreView Less

Related Point of Care

Screening for Colorectal Cancer
Annals of Internal Medicine; 160 (9): ITC5-1
Colorectal Cancer Screening
Annals of Internal Medicine; 148 (3): ITC2-1
View MoreView Less

Related Topics

Colorectal Cancer
Gastroenterology/Hepatology
Gastrointestinal Cancer
Hematology/Oncology

Colorectal Cancer, Gastroenterology/Hepatology, Gastrointestinal Cancer, Hematology/Oncology.

CME/MOC Activity Requires Users to be Registered and Logged In.
Sign in below to access your subscription for full content
INDIVIDUAL SIGN IN
Sign In|Set Up Account
You will be directed to acponline.org to register and create your Annals account
Annals of Internal Medicine
CREATE YOUR FREE ACCOUNT
Create Your Free Account|Why?
To receive access to the full text of freely available articles, alerts, and more. You will be directed to acponline.org to complete your registration.
×
The Comments Feature Requires Users to be Registered and Logged In.
Sign in below to access your subscription for full content
INDIVIDUAL SIGN IN
Sign In|Set Up Account
You will be directed to acponline.org to register and create your Annals account
Annals of Internal Medicine
CREATE YOUR FREE ACCOUNT
Create Your Free Account|Why?
To receive access to the full text of freely available articles, alerts, and more. You will be directed to acponline.org to complete your registration.
×
link to top

Content

  • Home
  • Latest
  • Issues
  • Channels
  • CME/MOC
  • In the Clinic
  • Journal Club
  • Web Exclusives

Information For

  • Author Info
  • Reviewers
  • Press
  • Readers
  • Institutions / Libraries / Agencies
  • Advertisers

Services

  • Subscribe
  • Renew
  • Alerts
  • Current Issue RSS
  • Latest RSS
  • In the Clinic RSS
  • Reprints & Permissions
  • Contact Us
  • Help
  • About Annals
  • About Mobile
  • Patient Information
  • Teaching Tools
  • Annals in the News
  • Share Your Feedback

Awards and Cover

  • Personae (Cover Photo)
  • Junior Investigator Awards
  • Poetry Prize

Other Resources

  • ACP Online
  • Career Connection
  • ACP Advocate Blog
  • ACP Journal Wise

Follow Annals On

  • Twitter Link
  • Facebook Link
acp link acp
silverchair link silverchair

Copyright © 2019 American College of Physicians. All Rights Reserved.

Print ISSN: 0003-4819 | Online ISSN: 1539-3704

Privacy Policy

|

Conditions of Use

This site uses cookies. By continuing to use our website, you are agreeing to our privacy policy. | Accept
×

You need a subscription to this content to use this feature.

×
PDF Downloads Require Access to the Full Article.
Sign in below to access your subscription for full content
INDIVIDUAL SIGN IN
Sign In|Set Up Account
You will be directed to acponline.org to register and create your Annals account
INSTITUTIONAL SIGN IN
Open Athens|Shibboleth|Log In
Annals of Internal Medicine
PURCHASE OPTIONS
Buy This Article|Subscribe
You will be redirected to acponline.org to sign-in to Annals to complete your purchase.
CREATE YOUR FREE ACCOUNT
Create Your Free Account|Why?
To receive access to the full text of freely available articles, alerts, and more. You will be directed to acponline.org to complete your registration.
×
Access to this Free Content Requires Users to be Registered and Logged In. Please Choose One of the Following Options
Sign in below to access your subscription for full content
INDIVIDUAL SIGN IN
Sign In|Set Up Account
You will be directed to acponline.org to register and create your Annals account
Annals of Internal Medicine
CREATE YOUR FREE ACCOUNT
Create Your Free Account|Why?
To receive access to the full text of freely available articles, alerts, and more. You will be directed to acponline.org to complete your registration.
×